[go: up one dir, main page]

AR103781A1 - Combinación de un retinoide y un diol y éster de ácido graso poliinsaturado - Google Patents

Combinación de un retinoide y un diol y éster de ácido graso poliinsaturado

Info

Publication number
AR103781A1
AR103781A1 ARP160100497A ARP160100497A AR103781A1 AR 103781 A1 AR103781 A1 AR 103781A1 AR P160100497 A ARP160100497 A AR P160100497A AR P160100497 A ARP160100497 A AR P160100497A AR 103781 A1 AR103781 A1 AR 103781A1
Authority
AR
Argentina
Prior art keywords
retinoid
combination
fatty acid
diol
acid ester
Prior art date
Application number
ARP160100497A
Other languages
English (en)
Original Assignee
Pierre Fabre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique filed Critical Pierre Fabre Dermo Cosmetique
Publication of AR103781A1 publication Critical patent/AR103781A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Reivindicación 1: Una combinación que comprende un retinoide y un compuesto de la fórmula general (1), donde: n es un número entero entre 0 y 15, m es 0, 1, 2 ó 3, y R es la cadena hidrocarbonada de un ácido graso poliinsaturado seleccionado de omega-3s y omega-6s. Reivindicación 5: La combinación de acuerdo con cualquiera de las reivindicaciones 1 a 4, donde el compuesto de fórmula general (1) se selecciona de las moléculas del grupo de fórmulas (2). Reivindicación 6: La combinación de acuerdo con cualquiera de las reivindicaciones 1 a 5, donde el retinoide se selecciona de retinol, retinaldehído, y ácido retinoico en sus diversas formas estereoisoméricas. Reivindicación 15: Un retinoide para uso tópico en la prevención de la formación de lesiones retencionales.
ARP160100497A 2015-02-27 2016-02-25 Combinación de un retinoide y un diol y éster de ácido graso poliinsaturado AR103781A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1551714A FR3033135B1 (fr) 2015-02-27 2015-02-27 Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature

Publications (1)

Publication Number Publication Date
AR103781A1 true AR103781A1 (es) 2017-05-31

Family

ID=53200134

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100497A AR103781A1 (es) 2015-02-27 2016-02-25 Combinación de un retinoide y un diol y éster de ácido graso poliinsaturado

Country Status (15)

Country Link
US (1) US10188625B2 (es)
EP (1) EP3261719B1 (es)
KR (1) KR20170122764A (es)
AR (1) AR103781A1 (es)
BR (1) BR112017017162A2 (es)
CA (1) CA2976605A1 (es)
ES (1) ES2839877T3 (es)
FR (1) FR3033135B1 (es)
MX (1) MX2017011028A (es)
PT (1) PT3261719T (es)
RU (1) RU2704109C2 (es)
TN (1) TN2017000363A1 (es)
TW (1) TW201639549A (es)
WO (1) WO2016135340A1 (es)
ZA (1) ZA201705670B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US20080139518A1 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
FR2940281B1 (fr) * 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
FR2940907B1 (fr) * 2009-01-15 2011-03-04 Oreal Composition cosmetique ou dermatologique, comprenant un retinoide, un compose non phosphate a base d'adenosine et un polymere semi-cristallin

Also Published As

Publication number Publication date
ZA201705670B (en) 2019-03-27
BR112017017162A2 (pt) 2018-04-03
RU2017131342A3 (es) 2019-05-17
EP3261719A1 (en) 2018-01-03
KR20170122764A (ko) 2017-11-06
RU2704109C2 (ru) 2019-10-24
TW201639549A (zh) 2016-11-16
TN2017000363A1 (en) 2019-01-16
US20180036275A1 (en) 2018-02-08
PT3261719T (pt) 2021-01-05
RU2017131342A (ru) 2019-03-28
MX2017011028A (es) 2017-11-10
ES2839877T3 (es) 2021-07-06
FR3033135A1 (fr) 2016-09-02
WO2016135340A1 (en) 2016-09-01
US10188625B2 (en) 2019-01-29
FR3033135B1 (fr) 2018-03-16
EP3261719B1 (en) 2020-09-30
CA2976605A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
MX2016008270A (es) Lipido que comprende acidos grasos poliinsaturados de cadena larga.
CL2019002663A1 (es) Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201702448)
MX377490B (es) Microcapsulas con alta deposicion en superficies.
CR20150579A (es) Composiciones y métodos para producir cetosis elevada y sostenida
CL2019001788A1 (es) Método para aislar lípidos a partir de una biomasa que contiene lípidos.
CL2015002239A1 (es) Moduladores de las enzimas modificadoras de los metilos, composiciones que los comprenden y sus usos
CO7121328A2 (es) Composiciones de ester de ácido graso omega -3
MX2017015990A (es) Composiciones topicas que comprenden un corticosteroide y un retinoide para tratar psoriasis.
CO2018008847A2 (es) Formulaciones líquidas inhibidoras de ureasa
CL2015001138A1 (es) Retiro de componentes indeseados de las composiciones de aceite
BR112014031284B8 (pt) composição, produto de cuidado pessoal, e, modificador de reologia
UY34112A (es) Composiciones farmacéuticas que contienen un agente neuroléptico y un inhibidor sglt2 y usos de los mismos
BR112015023334A2 (pt) processo para produção de (r)-3hidroxibutil (r)-3-hidroxibutirato
UY34111A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112016029033A2 (pt) processo para a produção de ésteres de éter glicólico com baixo teor de voc
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
MX383445B (es) Composiciones alimenticias para mascotas.
MX390089B (es) Composiciones de aceite refinado y métodos para su elaboración.
CL2013003823A1 (es) Procedimiento para revestir una superficie con micelas que comprenden un copolímero de bloque ab donde se expone la superficie con un líquido apolar que contiene las micelas y donde la superficie es un cristal agroquímico orgánico.
CO7250444A2 (es) Uso de seaprose para eliminar biopelículas bacterianas
ES2582927T3 (es) Adhesivo para la fabricación de laminados de productos de celulosa y procedimientos de fabricación de laminados de productos de celulosa
MX374738B (es) Aceite oxidativamente estable que contiene acidos grasos poliinsaturados.
MX2017002383A (es) Acidos ciclohexanocarboxilicos para enmascaramiento selectivo de sabor.
BR112019000371A2 (pt) composições líquidas para dispositivos de remoção de pelos que compreendem ésteres de poliol insaturados metatetizados
MX2018007191A (es) Composicion para beneficiar la piel a base de un solvente hidroxi funcionalizado.

Legal Events

Date Code Title Description
FB Suspension of granting procedure